Biobanking Market to Reach $68.08 Bn, Globally, by 2025 at 4.6% CAGR, Says Allied Market Research

Thursday, November 22, 2018 General News
Email Print This Page Comment bookmark
Font : A-A+

PORTLAND, Oregon, November 22, 2018 /PRNewswire/ --

Increase in funds for biobanking from private &

government organizations, high prevalence of chronic diseases, and increase in R&D activities for application of biobanking are expected to propel the growth of the global biobanking market. 


Market Research published a report, titled, "Biobanking Market by Specimen Type (Blood products, Solid tissue, and Cell lines), Type of Biobank (Population-Based Biobanks, and Disease-Oriented Biobanks), and Ownership (National/Regional agencies, Non-profit organization, University, and Private), and Application (Therapeutic, and Research): Global Opportunity Analysis and Industry Forecast, 2018-2025". The report presents in-depth analyses of the global biobanking market by closely monitoring the industry trends, drivers & opportunities, top investment pockets, key growth strategies, and competitive landscape. According to the report, the global biobanking market accounted for $47.06 billion in 2017 and is expected to reach $68.08 billion by 2023, registering CAGR of 4.6% during the forecast period.

     (Logo: )

Request Sample Report at:

Proactive support for biobanking by private & government organizations and high prevalence of chronic diseases drive the growth of the global biobanking market. However, ethical and legal issues associated with biobanking hamper the market growth. On the other hand, increase in R&D activities for application of biobanking and untapped opportunities in the developing regions are expected to create lucrative prospects for the market players in the coming years.

Solid tissue segment to manifest highest growth by 2025 

The solid tissue segment is expected to register the fastest CAGR of 5.9% during the study period, owing to increase in biomedical research and rise in drug discovery & genetic study. However, the blood products segment held the largest share, contributing about 43% share of the total revenue, owing to high demand for blood products, increase in the number of blood donors, and prevalence of chronic diseases. The cell lines segment would witness steady growth during the forecast period.

Research segment to lead the market throughout the study period 

The research segment held the largest share of the market, contributing more than two-thirds of the total revenue, as samples in biobank are used by researchers for various purposes such as drug discovery and identification of disease-relevant biomarkers. However, the therapeutic segment is estimated to manifest the fastest CAGR of 5.1% during the forecast period, owing to increase in awareness for biobanks and rise in focus on R&D related to the development of personalized medicines.

For Purchase Enquiry:

Population-based biobanks segment to manifest fastest CAGR through 2025 

The population-based biobanks segment is expected to witness the fastest CAGR of 5.2% during the forecast period, owing to large presence of population-based biobanks in developed countries such as UK, Sweden, and Denmark. However, the disease-oriented biobanks held the largest share of the market in 2017, contributing about 82% of the total revenue, owing to greater focus on improving diagnosis of disease and surge in the number of studies to develop therapies for critical diseases.

National/regional agency segment holds largest share in the market 

National/Regional agency segment contributed the largest share, accounting about 41% of the total revenue, owing to developments in the areas of genomics, personalized medicine, disease biology, and allied fields. However, the private segment is expected to register the fastest CAGR of 5.7% during the study period, as pharma and biotech companies have strengthened their presence in the biobank sector. The other segments analyzed in the report include non-profit organization and university.

Europe holds lion's share in the global biobanking market  

Europe held the largest market share in 2017, contributing about 41% of the total revenue and is projected to dominate the global market throughout the forecast period. However, Asia-Pacific region is expected to register the fastest CAGR of 5.7% from 2018 to 2025, owing to easy accessibility of cost-effective blood storage and increase in awareness toward the benefits of cord blood. Moreover, several companies have developed sharing platforms to ease the process of procuring cord blood units, which would boost the growth of the market in the Asia-Pacific region. The other regions analyzed in the report include North America and Latin America, Middle East and Africa (LAMEA).

Torchbearers of the market 

The key market players analyzed in the report include, ASKION GmbH, Cureline, Inc., Firalis S.A., LabVantage Solutions, Inc., PrecisionMed, Inc., CTI BIOTECH, Excilone SARL, Hamilton Company, LGC Limited, and ProMedDx LLC.

Access KNOWLEDGE TREE (Premium on-demand, subscription-based pricing model) at:

Knowledge tree is a cloud-based intelligence platform that offers more than 2,000 selective, off-the-shelf reports on niche markets to enable our clients gain deep insights on the latest trends, dynamic technologies, and emerging application areas. 

Purchase an enterprise user license and get 1 month complimentary access to our Knowledge Tree subscription. Offer valid till 15th November 2018. (*Terms and Conditions apply)

Get subscription:

Similar Reports: 

Biochips Market - Global Opportunity Analysis and Industry Forecast, 2018 - 2025

Metagenomics Market - Global Opportunity Analysis and Industry Forecast, 2017-2024

About Us 

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact: David Correa 5933 NE Win Sivers Drive #205, Portland, OR 97220 United States USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022, +1-503-446-1141 UK: +44-845-528-1300 Hong Kong: +852-301-84916 India (Pune): +91-20-66346060 Fax: +1(855)550-5975  


SOURCE Allied Market Research

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store